373 related articles for article (PubMed ID: 15987397)
1. Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units.
Muller A; Talon D; Potier A; Belle E; Cappelier G; Bertrand X
Crit Care; 2005 Jun; 9(3):R246-50. PubMed ID: 15987397
[TBL] [Abstract][Full Text] [Related]
2. [The influence of the use of mupirocin nasal ointment on the incidence of endogenous MRSA infections in an intensive care unit].
Hiramatsu N; Hashimoto S; Fujita N; Kageyama K; Ashida H; Kimura A; Kobayashi A; Tanaka Y
Masui; 2000 Aug; 49(8):867-71. PubMed ID: 10998878
[TBL] [Abstract][Full Text] [Related]
3. Can mupirocin prevent methicillin-resistant Staphylococcus aureus infections?
Wertheim HF; Vos MC
Crit Care; 2005 Jun; 9(3):257-8. PubMed ID: 15987417
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy of mupirocin in the prevention of infections with meticillin-resistant Staphylococcus aureus in a gastroenterology unit.
Dupeyron C; Campillo B; Richardet JP; Soussy CJ
J Hosp Infect; 2006 Aug; 63(4):385-92. PubMed ID: 16772100
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for ICU-acquired methicillin-resistant Staphylococcus aureus infections.
Oztoprak N; Cevik MA; Akinci E; Korkmaz M; Erbay A; Eren SS; Balaban N; Bodur H
Am J Infect Control; 2006 Feb; 34(1):1-5. PubMed ID: 16443085
[TBL] [Abstract][Full Text] [Related]
6. Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment.
Hitomi S; Kubota M; Mori N; Baba S; Yano H; Okuzumi K; Kimura S
J Hosp Infect; 2000 Oct; 46(2):123-9. PubMed ID: 11049705
[TBL] [Abstract][Full Text] [Related]
7. Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial.
Ellis MW; Griffith ME; Dooley DP; McLean JC; Jorgensen JH; Patterson JE; Davis KA; Hawley JS; Regules JA; Rivard RG; Gray PJ; Ceremuga JM; Dejoseph MA; Hospenthal DR
Antimicrob Agents Chemother; 2007 Oct; 51(10):3591-8. PubMed ID: 17682105
[TBL] [Abstract][Full Text] [Related]
8. Methicillin-resistant Staphylococcus aureus preventing strategy in cardiac surgery.
Mastoraki A; Kriaras I; Douka E; Mastoraki S; Stravopodis G; Geroulanos S
Interact Cardiovasc Thorac Surg; 2008 May; 7(3):452-6. PubMed ID: 18346978
[TBL] [Abstract][Full Text] [Related]
9. [Hospital personnel who are nasal carriers of methicillin-resistant Staphylococcus aureus. Usefulness of treatment with mupirocin].
Gaspar MC; Uribe P; Sánchez P; Coello R; Cruzet F
Enferm Infecc Microbiol Clin; 1992 Feb; 10(2):107-10. PubMed ID: 1643130
[TBL] [Abstract][Full Text] [Related]
10. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia.
Huang SS; Yokoe DS; Hinrichsen VL; Spurchise LS; Datta R; Miroshnik I; Platt R
Clin Infect Dis; 2006 Oct; 43(8):971-8. PubMed ID: 16983607
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Methicillin-Resistant Staphylococcus aureus (MRSA) and Use of a Nasal Mupirocin Ointment in Oral Cancer Inpatients.
Miyake M; Ohbayashi Y; Iwasaki A; Ogawa T; Nagahata S
J Oral Maxillofac Surg; 2007 Nov; 65(11):2159-63. PubMed ID: 17954308
[TBL] [Abstract][Full Text] [Related]
12. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients.
Lederer SR; Riedelsdorf G; Schiffl H
Eur J Med Res; 2007 Jul; 12(7):284-8. PubMed ID: 17933699
[TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic rhinosinusitis exacerbations due to methicillin-resistant Staphylococcus aureus with mupirocin irrigations.
Solares CA; Batra PS; Hall GS; Citardi MJ
Am J Otolaryngol; 2006; 27(3):161-5. PubMed ID: 16647979
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of preemptive barrier precautions in controlling nosocomial colonization and infection by methicillin-resistant Staphylococcus aureus in a burn unit.
Safdar N; Marx J; Meyer NA; Maki DG
Am J Infect Control; 2006 Oct; 34(8):476-83. PubMed ID: 17015152
[TBL] [Abstract][Full Text] [Related]
15. Surveillance for mupirocin resistance following introduction of routine peri-operative prophylaxis with nasal mupirocin.
Fawley WN; Parnell P; Hall J; Wilcox MH
J Hosp Infect; 2006 Mar; 62(3):327-32. PubMed ID: 16377029
[TBL] [Abstract][Full Text] [Related]
16. Intranasal mupirocin prophylaxis in elective surgery. A review of published studies.
Trautmann M; Stecher J; Hemmer W; Luz K; Panknin HT
Chemotherapy; 2008; 54(1):9-16. PubMed ID: 18063862
[TBL] [Abstract][Full Text] [Related]
17. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit.
Jones JC; Rogers TJ; Brookmeyer P; Dunne WM; Storch GA; Coopersmith CM; Fraser VJ; Warren DK
Clin Infect Dis; 2007 Sep; 45(5):541-7. PubMed ID: 17682986
[TBL] [Abstract][Full Text] [Related]
18. Topical antimicrobials in combination with admission screening and barrier precautions to control endemic methicillin-resistant Staphylococcus aureus in an Intensive Care Unit.
Gould IM; MacKenzie FM; MacLennan G; Pacitti D; Watson EJ; Noble DW
Int J Antimicrob Agents; 2007 May; 29(5):536-43. PubMed ID: 17337163
[TBL] [Abstract][Full Text] [Related]
19. [Methicillin-resistant Staphylococcus aureus nosocomial infections in ICU: risk factors, morbidity and cost].
Lepelletier D; Ferréol S; Villers D; Richet H
Pathol Biol (Paris); 2004 Oct; 52(8):474-9. PubMed ID: 15465267
[TBL] [Abstract][Full Text] [Related]
20. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections.
Perl TM; Cullen JJ; Wenzel RP; Zimmerman MB; Pfaller MA; Sheppard D; Twombley J; French PP; Herwaldt LA;
N Engl J Med; 2002 Jun; 346(24):1871-7. PubMed ID: 12063371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
